☆ 4.8 Letter

Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Get Full Text
Add to Collection

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 384, Issue 7, Pages 673-674

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2030164

Keywords

-

Categories

Medicine, General & Internal

Funding

  1. Novartis
  2. Lymphoma Research Foundation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.